Prescribing for the Elderly & AGS Beers Criteria® Case Studies (3 Detailed Patient Cases) – Advanced Pharmacology

Prescribing for the Elderly & AGS Beers Criteria® Case Studies (3 Detailed Patient Cases) – Advanced Pharmacology Comprehensive, fully completed geriatric pharmacology assignment analyzing the 2023 American Geriatrics Society (AGS) Beers Criteria® across three clinical case scenarios. This resource provides in-depth pharmacodynamic/pharmacokinetic analysis, creatinine clearance (CrCl) calculations, medication safety evaluations, and evidence-based deprescribing strategies. Key Assignment Highlights & Completed Sections:Part 1: Pharmacology Fundamentals in Geriatrics: Clear explanations of pharmacodynamics, pharmacokinetics (absorption, distribution, metabolism, excretion), and age-related physiological changes impacting drug clearance, sensitivity, and toxicity risks. Part 2: AGS Beers Criteria® Case Applications: Complete structured tables evaluating specific medications against Beers Criteria tables (e.g., Table 2, Table 3) including recommendations (Avoid, Avoid with Parameters, Use with Caution), rationale, potential adverse reactions (e.g., falls, hypoglycemia, hyperkalemia, CNS depression), and specific drug modification/replacement plans: Case 1 (75yo female post-fall & mild confusion): Analysis of Aspirin 81 mg, Glimepiride 4 mg, Simvastatin 20 mg, Novolog sliding scale, Oxycodone 5 mg, APAP 650 mg, and Multivitamin. Case 2 (78yo male with AFib, CVA, BPH & CKD - CrCl 60.6 mL/min): Evaluation of Digoxin (toxic dosing 0.125 mg/day), Toprol XL, Alfuzosin ER, Aspirin, Rivaroxaban, Levothyroxine, Finasteride, Insulin Glargine, Novolog sliding scale, and Gabapentin. Case 3 (93yo female with HFrEF EF 28%, CKD - CrCl 26.8 mL/min & K+ 5.2): Analysis of Diltiazem ER (contraindicated in HFrEF), Lasix, Lisinopril, Ibuprofen (NSAID avoidance in CKD/CHF), Atorvastatin, and Triamterene/HCTZ (hyperkalemia risk). General Geriatric Prescribing & Deprescribing Questions: Guidance on safe/unsafe antidepressants/antianxiety agents in older adults, step-down tapering protocols for deprescribing, and professional therapeutic communication strategies for educating patients on medication changes without undermining prior providers. Target Audience: Perfect study guide and reference for Family Nurse Practitioner (FNP), Adult-Gerontology Primary Care (AGPCNP), MSN, DNP, Doctor of Pharmacy (PharmD), and Physician Assistant (PA) students studying advanced pharmacology, gerontology, and polypharmacy management.